ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
14.65
-0.33 (-2.20%)
May 27, 2025, 3:41 PM - Market open
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.44 billion as of May 27, 2025. Its market cap has increased by 63.90% in one year.
Market Cap
1.44B
Enterprise Value
1.31B
1-Year Change
63.90%
Ranking
Category
Stock Price
$14.65
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.44B, an increase of 153.20%. That is a compound annual growth rate of 44.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 1.47B | 43.49% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.89B |
| Johnson & Johnson | 366.47B |
| AbbVie | 327.08B |
| Novo Nordisk | 311.77B |
| UnitedHealth Group | 265.23B |
| Abbott Laboratories | 231.86B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |